Unnamed: 0,title,date,stock,sentiment
1243073.0,"B of A Securities Maintains Neutral on Tandem Diabetes Care, Raises Price Target to $95",2020-05-22 11:51:00-04:00,TNDM,positive
1243074.0,"Citigroup Maintains Neutral on Tandem Diabetes Care, Raises Price Target to $81",2020-05-01 12:37:00-04:00,TNDM,positive
1243075.0,"UBS Maintains Buy on Tandem Diabetes Care, Lowers Price Target to $98",2020-05-01 12:34:00-04:00,TNDM,positive
1243076.0,"Stifel Maintains Hold on Tandem Diabetes Care, Raises Price Target to $75",2020-05-01 08:54:00-04:00,TNDM,positive
1243077.0,"SVB Leerink Maintains Market Perform on Tandem Diabetes Care, Raises Price Target to $88",2020-05-01 06:52:00-04:00,TNDM,positive
1243078.0,Tandem Diabetes Care shares are trading higher after the company reported better-than-expected Q1 sales results.,2020-04-30 16:14:00-04:00,TNDM,positive
1243079.0,Tandem Diabetes Sees Q2 Sales $85M+,2020-04-30 16:13:00-04:00,TNDM,neutral
1243080.0,"Tandem Diabetes Care Q1 EPS $(0.250) Misses $(0.170) Estimate, Sales $97.900M Beat $84.460M Estimate",2020-04-30 16:12:00-04:00,TNDM,positive
1243081.0,Tandem Diabetes Care shares are trading higher. Not seeing any news to justify the price action. NOTE: The company is reporting earnings today after the close.,2020-04-30 12:09:00-04:00,TNDM,positive
1243082.0,"Raymond James Maintains Outperform on Tandem Diabetes Care, Lowers Price Target to $81",2020-04-27 11:40:00-04:00,TNDM,positive
1243083.0,SVB Leerink Downgrades Tandem Diabetes Care to Market Perform,2020-04-24 07:57:00-04:00,TNDM,positive
1243084.0,"Citigroup Maintains Neutral on Tandem Diabetes Care, Lowers Price Target to $74",2020-03-27 09:12:00-04:00,TNDM,positive
1243085.0,Tandem Diabetes Care Announces Security Incident With Five Employee Email Accounts',2020-03-16 16:09:00-04:00,TNDM,positive
1243086.0,Tandem Diabetes Reports FDA Designation Of Basal-IQ Technology As Interoperable Automated Glycemic Controller,2020-03-02 09:04:00-05:00,TNDM,neutral
1243087.0,"Piper Sandler Maintains Overweight on Tandem Diabetes Care, Raises Price Target to $90",2020-02-25 09:18:00-05:00,TNDM,positive
1243088.0,Tandem Diabetes Care shares are trading lower after the company reported worse-than-expected Q4 sales results.,2020-02-25 09:09:00-05:00,TNDM,positive
1243089.0,"Stifel Nicolaus Maintains Hold on Tandem Diabetes Care, Raises Price Target to $77",2020-02-25 08:55:00-05:00,TNDM,positive
1243090.0,"Raymond James Maintains Outperform on Tandem Diabetes Care, Raises Price Target to $91",2020-02-25 07:51:00-05:00,TNDM,positive
1243091.0,Tandem Diabetes Care shares are trading lower after the company reported worse-than-expected Q4 sales results.,2020-02-24 16:19:00-05:00,TNDM,positive
1243092.0,Tandem Diabetes Care Sees FY20 Sales $450M-$465M vs $444.62M Est.,2020-02-24 16:13:00-05:00,TNDM,positive
1243093.0,"Tandem Diabetes Care Q4 EPS $0.04 Does Not Compare To $(0.05) Estimate, Sales $108.4M Miss $109.22M Estimate",2020-02-24 16:12:00-05:00,TNDM,positive
1243094.0,Tandem Diabetes Care Highlights Presentation Of Data On Its Automated Insulin Delivery Technologies,2020-02-20 12:18:00-05:00,TNDM,positive
1243095.0,"Craig-Hallum Reiterates Buy, $92 Target On Tandem Diabetes Notes 'FDA Ups The Ante With A Class I Recall Of Medtronic's 600-Series Pumps. Puts Additional Pressure On MDT, Lends Support For Tandem Going In-Network With UNH'",2020-02-12 13:56:00-05:00,TNDM,positive
1243096.0,"Tandem Diabetes shares are trading higher, not currently seeing company-specific news. Wellington Group earlier disclosed a 10.24% passive stake in the company.",2020-02-10 11:43:00-05:00,TNDM,positive
1243097.0,"Raymond James Initiates Coverage On Tandem Diabetes Care with Outperform Rating, Announces $85 Price Target",2020-02-06 05:05:00-05:00,TNDM,positive
1243098.0,"UPDATE: Baird Downgrades Tandem Diabetes Care to Neutral, Raises Price Target to $75 As Firm Notes 3 Potential Catalysts:",2020-02-04 11:04:00-05:00,TNDM,positive
1243099.0,"Baird Downgrades Tandem Diabetes Care to Neutral, Raises Price Target to $75",2020-02-04 05:33:00-05:00,TNDM,positive
1243100.0,Tandem Diabetes shares are trading higher. Not currently seeing any company-specific news.,2020-01-29 11:00:00-05:00,TNDM,positive
1243101.0,Tandem Diabetes Care Announces Commercial Launch Of t:slim X2 Insulin Pump With Control-IQ Technology In The United States,2020-01-15 16:05:00-05:00,TNDM,positive
1243102.0,Tandem Diabetes Care shares are trading higher after the company announced it received FDA clearance for its t:slim X2 Insulin Pump with Control-IQ advanced hybrid closed-loop technologies.,2019-12-13 14:30:00-05:00,TNDM,positive
1243103.0,Tandem Diabetes Shares Resume Trading Higher,2019-12-13 14:02:00-05:00,TNDM,positive
1243104.0,Tandem Diabetes Care Announces FDA Clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology,2019-12-13 13:36:00-05:00,TNDM,positive
1243105.0,Watching shares of DexCom And Insulet After Rival Tandem Received FDA Marketing Authorization For Diabetes Care Control-IQ Technology,2019-12-13 11:56:00-05:00,TNDM,positive
1243106.0,FDA Authorizes Marketing Of Tandem Diabetes Care Control-IQ Technology,2019-12-13 11:54:00-05:00,TNDM,positive
1243107.0,Tandem Diabetes Care shares are trading lower on seemingly no company-specific news.,2019-12-04 11:40:00-05:00,TNDM,positive
1243108.0,Tandem Diabetes Care Announces Health Canada Approval Of t:slim X2 Insulin Pump With Basal-IQ Predictive Low-Glucose Suspend Technology,2019-11-20 09:01:00-05:00,TNDM,positive
1243109.0,Tandem Diabetes Care shares are trading higher. Not seeing any news to justify the price action.,2019-11-19 15:57:00-05:00,TNDM,positive
1243110.0,"Tandem Diabetes Shares Rebound From Session Low; Hearing Cowen Defending, Says Sees Highly Unlikely Tandem Is Not At Fault Amid Report Of Patient Death",2019-11-08 11:58:00-05:00,TNDM,negative
1243111.0,"Tandem Diabetes shares are trading lower following a posting on the FDA Adverse Event site indicating a user died, with blood glucose being low at the time of death. This has lead some investors to speculate a potential malfunction.",2019-11-08 11:42:00-05:00,TNDM,negative
1243112.0,FDA Adverse Event Site Shows Listing For Tandem T:Slim X2 Insulin Pump Reporting That A Customer Has Died And Blood Glucose Was Low At Time Of Death,2019-11-08 10:49:00-05:00,TNDM,negative
1243113.0,Tandem Diabetes Care shares are trading higher despite no company-specific news. This could potentially be a rebound after the stock dropped approximately 8% over the past 4 trading sessions.,2019-11-07 11:50:00-05:00,TNDM,positive
1243114.0,"Baird Maintains Outperform on Tandem Diabetes Care, Lowers Price Target to $71",2019-11-05 08:36:00-05:00,TNDM,positive
1243115.0,Tandem Diabetes Care shares are trading lower despite the company reporting better-than-expected Q3 EPS and sales results.,2019-11-05 08:04:00-05:00,TNDM,positive
1243116.0,Tandem Diabetes Care shares are trading lower despite the company reporting better-than-expected Q3 EPS and sales results.,2019-11-04 17:04:00-05:00,TNDM,positive
1243117.0,Tandem Diabetes Care Sees FY19 Sales $358M-$365M vs $360.98M Est.,2019-11-04 16:20:00-05:00,TNDM,positive
1243118.0,"Tandem Diabetes Care Q3 EPS $(0.09) Beats $(0.2) Estimate, Sales $94.66M Beat $89.14M Estimate",2019-11-04 16:20:00-05:00,TNDM,positive
1243119.0,"Guggenheim Initiates Coverage On Tandem Diabetes Care with Buy Rating, Announces $76 Price Target",2019-10-18 06:46:00-04:00,TNDM,positive
1243120.0,Tandem Diabetes Care shares are trading higher after the company announced the publication by NEJM of the landmark Protocol 3 study demonstrating increased time-in-range with the t:slim x2 insulin pump witith control-IQ technology.,2019-10-17 15:00:00-04:00,TNDM,positive
1243121.0,Tandem Diabetes Care shares are trading higher after the company announced it is collaborating with Abbot to explore new integrated solutions to improve diabetes management.,2019-10-15 09:18:00-04:00,TNDM,positive
1243122.0,Abbott And Tandem Diabetes To Collaborate To Develop And Commercialize Integrated Diabetes Solutions That Combine Abbott's Glucose Sensing Technology With Tandem's Insulin Delivery Systems,2019-10-15 08:06:00-04:00,TNDM,positive
1243123.0,Tandem Diabetes Care shares are trading higher after UBS upgraded the stock from Neutral to Buy and announced a price target of $75 per share.,2019-10-04 09:11:00-04:00,TNDM,positive
1243124.0,"UBS Upgrades Tandem Diabetes Care to Buy, Announces $75 Price Target",2019-10-04 07:17:00-04:00,TNDM,positive
1243125.0,Tandem Diabetes Care shares are trading lower. Not seeing any news to justify the price action.,2019-09-26 11:23:00-04:00,TNDM,positive
1243126.0,Tandem Diabetes Care Highlights Publication Of Real-World Basal-IQ Predictive Low Glucose Suspend Technology Data In Diabetes Technology And Therapeutics Journal,2019-09-18 16:17:00-04:00,TNDM,negative
1243127.0,Tandem Diabetes shares are trading higher on seemingly no company-specific news.,2019-08-22 15:19:00-04:00,TNDM,neutral
1243128.0,Tandem Diabetes Care shares are trading lower following the disclosure that company executives sold shares of the stock.,2019-08-07 15:03:00-04:00,TNDM,positive
1243129.0,"Tandem Diabetes Shares Down 5% Following Disclosure Of Insider Sales Tue. Afternoon: 4 Execs/Directors Sold ~26K Shares, Of Which ~7K Shares Were Related To Option Exercise And 10b5-1 Trading Plan",2019-08-07 14:33:00-04:00,TNDM,positive
1243130.0,Tandem Diabetes shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.,2019-08-02 08:23:00-04:00,TNDM,positive
1243131.0,"Tandem Diabetes Care Q2 EPS $(0.03) Beats $(0.25) Estimate, Sales $93.255M Beat $70.03M Estimate",2019-08-01 16:49:00-04:00,TNDM,positive
1243132.0,"Shares of several healthcare companies are trading lower after Trump on Friday said he was preparing an executive order declaring a 'favored nations clause' for drug prices, lowering the price that consumers will pay prescription drugs.",2019-07-08 12:55:00-04:00,TNDM,positive
1243133.0,"Piper Jaffray Analyst JP Kim Comments On Downside In Tandem Diabetes Fri., Tells Benzinga 'There are rumors of a short report from Wall Street Associates.'",2019-06-14 15:21:00-04:00,TNDM,positive
1243134.0,"Trader Idea Feed: 'Worth watching the $72.05 area in this Tandem Diabetes. This stock has that ""angry"" look... if it breaks resistance, it could make a fierce run up to $80 area' @traderstewie Via Twitter",2019-06-12 14:59:00-04:00,TNDM,positive
1243135.0,Tandem Diabetes Care Late Sunday Reported Results From Two Studies Of The T:Slim X2 Insulin Pump With Control-IQ Technology,2019-06-10 10:04:00-04:00,TNDM,positive
1243136.0,"Shares of many Healthcare companies are trading higher as markets rebound from the recent volatility caused by uncertainty regarding US-China trade talks. Also, lawmakers were not able to pass a bill that would end 'surprise medical bills'.",2019-05-16 15:09:00-04:00,TNDM,positive
1243137.0,"SVB Leerink Initiates Coverage On Tandem Diabetes Care, Inc. - Common Stock with Outperform Rating, Announces $83 Price Target",2019-05-13 09:40:00-04:00,TNDM,positive
1243138.0,"Stifel Nicolaus Maintains Hold on Tandem Diabetes Care, Inc. - Common Stock, Raises Price Target to $70",2019-05-01 11:14:00-04:00,TNDM,positive
1243139.0,"Tandem Diabetes Raises FY19 Sales Guidance From $255M-$270M To $300M-$315M vs $266.5M Estimate, Adj. EBITDA Breakeven To Positive",2019-04-30 17:07:00-04:00,TNDM,positive
1243140.0,"Tandem Diabetes Care Q1 EPS $(0.18) Beats $(0.3) Estimate, Sales $65.995M Beat $47.51M Estimate",2019-04-30 17:06:00-04:00,TNDM,positive
1243141.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,TNDM,positive
1243142.0,American Diabetes Association Issues Critical Updates To The 2019 Standards Of Medical Care In Diabetes,2019-03-27 15:33:00-04:00,TNDM,positive
1243143.0,'Amazon-exclusive medical brand Choice expands services with One Drop partnership' -Digiday Reported On Tuesday,2019-03-21 10:36:00-04:00,TNDM,negative
1243144.0,"BMO Capital Initiates Coverage On Tandem Diabetes Care with Outperform Rating, Announces $77 Price Target",2019-03-08 07:01:00-05:00,TNDM,positive
1243145.0,"Tandem Diabetes Care Reports ADP In Ontario, Canada Approved Co. Insulin Pump",2019-03-07 16:20:00-05:00,TNDM,positive
1243146.0,Tandem Diabetes Care shares are trading lower after the company announced that it will use its remote software update tool to resolve a rare bug that might cause problems for the ongoing DCLP 3 phase of its IDCL trial.,2019-03-06 13:27:00-05:00,TNDM,positive
1243147.0,Tandem Diabetes Reports Intent To Use Tandem Device Updater To Resolve Control-IQ Technology Software Anomaly Identified During Ongoing DCLP3 Phase Of IDCL Trial,2019-03-06 09:18:00-05:00,TNDM,positive
1243148.0,"US Senator Ron Wyden Says Finance Committee Continuing To Investigate How Major Insulin Manufacturers Set, Increase 'Outrageous Price Of Insulin'",2019-03-04 12:28:00-05:00,TNDM,negative
1243149.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Thurs., Feb. 28, 2019",2019-02-28 09:15:00-05:00,TNDM,positive
1243150.0,Tandem Diabetes Care shares are trading higher after the company reported better than expected Q4 EPS and revenue results. The company also announced 2019 revenue guidance of $255 million to $270 million versus the $220 million analyst estimate.,2019-02-27 09:18:00-05:00,TNDM,positive
1243151.0,"Tandem Diabetes Reports Pres, CEO Kim Blickenstaff To Transition To Role As Exec Chair; COO John Sheridan Named Replacement At Pres, CEO",2019-02-26 16:26:00-05:00,TNDM,neutral
1243152.0,"Tandem Diabetes Sees FY19 Adj. EBITDA Breakeven, Sales $255M-$270M vs $219.5M Estimate",2019-02-26 16:25:00-05:00,TNDM,neutral
1243153.0,"Tandem Diabetes Care Q4 EPS $0.02 Beats $(0.20) Estimate, Sales $76.199M Beat $56.34M Estimate",2019-02-26 16:24:00-05:00,TNDM,positive
1243154.0,FDA Permits Marketing Of Tandem's T: SLIM X2 Insulin Pump,2019-02-14 15:33:00-05:00,TNDM,neutral
1243155.0,"UBS Initiates Coverage On Tandem Diabetes Care with Neutral Rating, Announces $36 Price Target",2018-11-28 08:20:00-05:00,TNDM,positive
1243156.0,Tandem Diabetes Care shares trading up 15.3% after analysts at Baird upgraded the stock from 'Neutral' to 'Outperform'.,2018-11-21 14:38:00-05:00,TNDM,positive
1243157.0,"Baird Upgrades Tandem Diabetes Care to Outperform, Announces $46 Price Target",2018-11-21 07:08:00-05:00,TNDM,positive
1243158.0,Tandem Diabetes Sees FY18 Sales $160M-$165M vs $155.42M Est.,2018-11-01 17:00:00-04:00,TNDM,neutral
1243159.0,"Tandem Diabetes Care Q3 EPS $(0.62) Misses $(0.33) Estimate, Sales $46.264M Beat $41.83M Estimate",2018-11-01 17:00:00-04:00,TNDM,positive
1243160.0,"Hearing Piper Jaffray Out Saying Medtronic's Trial Start Date For A Product Delayed In Order To Compete With Tandem Diabetes Care's Product, Says This Gives Tandem 6 Months Runway; Unconfirmed",2018-11-01 12:43:00-04:00,TNDM,negative
1243161.0,Tandem Diabetes Receives Canada Approval to Market t:slim X2 Insulin Pump,2018-10-12 17:03:00-04:00,TNDM,positive
1243162.0,Tandem Diabetes Care shares are trading up 8.7% after the company raised its 2018 sales guidance and issued upbeat guidance for Q3; The company cited continued strong domestic sales and the launch of the t:slim X2 insulin pump as drivers of guidance.,2018-09-25 12:22:00-04:00,TNDM,positive
1243163.0,"UPDATE: Tandem Diabetes, On Raised FY18 Sales Guidance, Cited 'continued strong domestic sales in the third quarter and the recent launch of the t:slim X2™ Insulin Pump in select international markets'",2018-09-25 09:03:00-04:00,TNDM,positive
1243164.0,Tandem Diabetes Sees Q3 Sales $42M-$44M vs $35.43M Estimate,2018-09-25 09:03:00-04:00,TNDM,neutral
1243165.0,UPDATE: Tandem Diabetes Raises FY18 Sales From $140M-$148M To $150M-$158M vs $146.8M Estimate,2018-09-25 09:02:00-04:00,TNDM,neutral
1243166.0,Tandem Diabetes Raises FY18 Sales Guidance,2018-09-25 09:01:00-04:00,TNDM,neutral
1243167.0,"Craig-Hallum Initiates Coverage On Tandem Diabetes Care with Buy Rating, Announces $52 Price Target",2018-09-20 07:47:00-04:00,TNDM,positive
1243168.0,Tandem Diabetes Shares Down 11.2% As Traders Note Offering Lockup Expiration Due To Expire After Hours Today,2018-09-18 11:12:00-04:00,TNDM,positive
1243169.0,Traders Circulating Chatter That United Health Deems Tandem's Newest T:slim CGM Produt Line Wasn't Medically Necessary Under Their Coverage Policy,2018-09-18 09:55:00-04:00,TNDM,positive
1243170.0,"Stocks Which Set New 52-Week High Yesterday, September 13th",2018-09-14 09:26:00-04:00,TNDM,neutral
1243171.0,Baird Downgrades Tandem Diabetes Care to Neutral,2018-09-14 06:10:00-04:00,TNDM,positive
1243172.0,"Stocks Which Set New 52-Week High Yesterday, September 12",2018-09-13 09:44:00-04:00,TNDM,neutral
1243173.0,"Stocks Which Set New 52-Week High Yesterday, September 5th",2018-09-06 08:48:00-04:00,TNDM,neutral
1243174.0,"Stocks Which Set New 52-Week High Yesterday, September 4th",2018-09-05 10:22:00-04:00,TNDM,neutral
1243175.0,"Baird Healthcare Conference Begins Today, Presenters Include: Tandem Diabetes, Acadia Healthcare, and Tenet Healthcare",2018-09-05 06:52:00-04:00,TNDM,neutral
1243176.0,"Stocks Which Set New 52-Week High Friday, August 31",2018-09-04 10:29:00-04:00,TNDM,neutral
1243177.0,"Stocks Which Set New 52-Week High Yesterday, August 30th",2018-08-31 10:11:00-04:00,TNDM,neutral
1243178.0,"Berenberg Initiates Coverage On Tandem Diabetes Care with Buy Rating, Announces $50 Price Target",2018-08-30 07:29:00-04:00,TNDM,positive
1243179.0,"Stocks Which Set New 52-Week High Yesterday, August 28th",2018-08-29 11:13:00-04:00,TNDM,neutral
1243180.0,"Stocks Which Set New 52-Week High Friday, August 24th",2018-08-27 09:24:00-04:00,TNDM,neutral
1243181.0,"Dougherty Initiates Coverage On Tandem Diabetes Care with Buy Rating, Announces $45 Price Target",2018-08-24 10:07:00-04:00,TNDM,positive
1243182.0,"Stocks Which Set New 52-Week High Yesterday, August 23rd",2018-08-24 09:11:00-04:00,TNDM,neutral
1243183.0,"Bank of America Upgrades Tandem Diabetes Care to Neutral, Raises Price Target to $45",2018-08-24 09:00:00-04:00,TNDM,positive
1243184.0,"Stocks Which Set New 52-Week High Yesterday, August 22nd",2018-08-23 10:51:00-04:00,TNDM,neutral
1243185.0,"Stocks Which Set New 52-Week High Yesterday, August 21st",2018-08-22 09:06:00-04:00,TNDM,neutral
1243186.0,"Stifel Transfers Coverage Of Tandem Diabetes To Mathew Blackman, Maintains Hold And Increases Price Target From $25 To $34",2018-08-22 07:09:00-04:00,TNDM,neutral
1243187.0,"Stocks Which Set New 52-Week High Tues., Aug. 21, 2018",2018-08-21 14:50:00-04:00,TNDM,neutral
1243188.0,"Stocks Which Set New 52-Week High Yesterday, August 16th",2018-08-17 10:39:00-04:00,TNDM,neutral
1243189.0,Tandem Diabetes Care Announces Launch of t:slim X2 Insulin Pump in the U.S.,2018-08-17 09:00:00-04:00,TNDM,positive
1243190.0,"Stocks Which Set New 52-Week High Yesterday, August 15th",2018-08-16 10:22:00-04:00,TNDM,neutral
1243191.0,"Tandem Diabetes Care Highlights Publication Of PROLOG Study Results In Diabetes Care Journal, Showed 't:slim X2 Pump with Basal-IQ Technology significantly reduced hypoglycemia without rebound hyperglycemia'",2018-08-08 09:04:00-04:00,TNDM,positive
1243192.0,"Stocks Which Set New 52-Week High Yesterday, August 6th",2018-08-07 11:27:00-04:00,TNDM,neutral
1243193.0,"Stocks Which Set New 52-Week Highs Friday, August 3rd",2018-08-06 13:02:00-04:00,TNDM,neutral
1243194.0,"Stocks Which Set New 52-Week High Yesterday, August 2nd",2018-08-03 11:16:00-04:00,TNDM,neutral
1243195.0,Tandem Diabetes Care Prices ~3.51M Share Common Stock Offering At $28.50/Share,2018-08-03 09:03:00-04:00,TNDM,positive
1243196.0,"Tandem Diabetes Care Announces Proposed Underwritten Common Stock Offering, No Size Disclosed",2018-08-02 16:08:00-04:00,TNDM,positive
1243197.0,"Stocks Which Set New 52-Week High Yesterday, August 1st",2018-08-02 10:56:00-04:00,TNDM,neutral
1243198.0,Tandem Diabetes Care Inc. Shares Up 12% After Co. Announces 2Q18 Earnings; Sales Rose 60% YoY,2018-07-31 11:47:00-04:00,TNDM,positive
1243199.0,"Stifel Nicolaus Maintains Hold on Tandem Diabetes Care, Raises Price Target to $25",2018-07-31 07:23:00-04:00,TNDM,positive
1243200.0,Tandem Diabetes FY18 Sales $140M-$148M vs $140.9M Estimate,2018-07-30 16:12:00-04:00,TNDM,neutral
1243201.0,"Tandem Diabetes Care Q2 EPS $(1.17) May Not Compare $(0.35) Estimate, Sales $34.126M Beat $29.67M Estimate",2018-07-30 16:12:00-04:00,TNDM,positive
1243202.0,"Stocks Which Set New 52-Week High Yesterday, July 24th:",2018-07-25 12:14:00-04:00,TNDM,neutral
1243203.0,"Tandem Diabetes Shares Volatile Here, Down 3.5% From Session High; Traders Circulating FDA.gov Access Data Alert Highlighting MAUDE Adverse Event Report For Co.'s T:Slim Insulin Delivery System Insulin Pump",2018-07-06 10:30:00-04:00,TNDM,positive
1243204.0,Tandem Diabetes Care Reports FDA Approval of t:slim X2 Insulin Pump with Basal-IQ Technology,2018-06-21 16:05:00-04:00,TNDM,positive
1243205.0,"Lake Street Initiates Coverage On Tandem Diabetes Care with Buy Rating, Announces $30 Price Target",2018-06-18 09:21:00-04:00,TNDM,positive
1243206.0,Tandem Diabetes Shares Fall To Low Of $15.72/Share Down ~10%,2018-06-13 12:34:00-04:00,TNDM,neutral
1243207.0,"Tandem Diabetes Care Shares Up 24.1% After Piper Jaffray Earlier Upgraded To Overweight; Firm Said Co. Is Entering A ""Goldilocks Period"" Of Several Years With A ""Superior"" Closed Loop",2018-05-14 15:55:00-04:00,TNDM,positive
1243208.0,PiperJaffray Upgrades Tandem Diabetes Care to Overweight,2018-05-14 08:20:00-04:00,TNDM,positive
1243209.0,"Deutsche Bank Health Care Conference Begins Today, Presenters Include: Humana, Tandem Diabetes Care, Alnylam, Vocera, and Celgene",2018-05-08 07:03:00-04:00,TNDM,positive
1243210.0,Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump,2018-04-30 08:37:00-04:00,TNDM,positive
1243211.0,Tandem Diabetes Shares Down 18.0% After Hours Following Mixed Q1 Results And Announcement Of $100M Offering,2018-04-26 17:31:00-04:00,TNDM,positive
1243212.0,"Tandem Diabetes Care Q1 EPS $(1.82) Misses $(0.59) Est., Sales $27.2M Beats $25.3M Est.",2018-04-26 16:04:00-04:00,TNDM,positive
1243213.0,"Tandem Diabetes Care Reports Deals For Distribution Of Insulin Pump Products In Australia, New Zealand",2018-04-23 16:37:00-04:00,TNDM,positive
1243214.0,StreetSweeper Follows Tweet Wednesday On Tandem Diabetes With A Full Alert Issued Today,2018-04-19 10:26:00-04:00,TNDM,positive
1243215.0,"'$TDNM When the CEO sells, we sell! CEO sold 132,444 shares Monday immediately after cashless exercise.'-Street Sweeper Tweet",2018-04-18 10:33:00-04:00,TNDM,positive
1243216.0,Tandem Diabetes Shares Up 22.6% After Earlier Reporting Prelim. Q1 Sales Above The Consensus View,2018-04-10 14:59:00-04:00,TNDM,positive
1243217.0,Cowen & Co. Upgrades Tandem Diabetes Care to Outperform,2018-03-28 07:30:00-04:00,TNDM,positive
1243218.0,"Tandem Diabetes Shares Up 6.9% After Co. Thursday Reported Strong Q4 Results And FY18 Guidance, Baird Earlier Upgraded To Outperform",2018-03-23 12:07:00-04:00,TNDM,positive
1243219.0,Baird Upgrades Tandem Diabetes Care to Outperform,2018-03-23 07:22:00-04:00,TNDM,positive
1243220.0,Tandem Diabetes Care Sees FY18 Sales $132-$140M vs $132M Est.,2018-03-01 16:00:00-05:00,TNDM,positive
1243221.0,"Tandem Diabetes Care Reports Q4 EPS $(1.23) vs $(1.30) Est., Sales $40.29M vs $37.9M Est.",2018-03-01 16:00:00-05:00,TNDM,positive
1243222.0,"Cowen Raises Tandem Diabetes From $2.50 To $5 As Cowen Believes The Co. Has A Plausible Path To Cash Flow Breakeven, Says Recent Equity Financing Removes Stock's Biggest Overhang",2018-02-27 09:47:00-05:00,TNDM,neutral
1243223.0,"Oppenheimer Initiates Coverage On Tandem Diabetes Care with Outperform Rating, Announces $5.50 Price Target",2018-02-27 08:43:00-05:00,TNDM,positive
1243224.0,Tandem Diabetes Care Applies for Health Canada Medical Device License,2018-02-20 16:51:00-05:00,TNDM,positive
1243225.0,Tandem Diabetes Reports Distribution Deal With Rubin Medical For Insulin Pump Products In Scandinavia,2018-02-15 16:33:00-05:00,TNDM,neutral
1243226.0,Tandem Diabetes Reports Pivotal Trial For t:slim X2 Insulin Pump Reduced Time In Hypoglycemia,2018-02-15 09:20:00-05:00,TNDM,neutral
1243227.0,Tandem Diabetes Prices 30M Share Offering At $2/Share,2018-02-09 08:32:00-05:00,TNDM,positive
1243228.0,Tandem Diabetes Shares Up 19.196% After Tuesday Reporting Prelim Q4 and FY18 Sales Above Street Estimates,2018-01-10 11:24:00-05:00,TNDM,positive
1243229.0,Tandem Diabetes Sees FY18 Sales $132M-$140M vs $133.6M Est.,2018-01-09 16:17:00-05:00,TNDM,neutral
1243230.0,Tandem Diabetes Sees Q4 Sales $39M-$40M vs $34.4M Est.; Sees FY17 Adj. Sales $101M-$102M vs 98.3M Est.,2018-01-09 16:16:00-05:00,TNDM,neutral
1243231.0,UPDATE: Tandem Diabetes Confirms IDCL Multi-site Study Timeline,2018-01-08 09:18:00-05:00,TNDM,neutral
1243232.0,"Tandem Diabetes Care Reports Successful Completion Of First Pilot Study Using t:slim X2 Insulin Pump With TypeZero Hybrid Closed Loop Technology, Dexcom G6 Integration",2018-01-08 09:18:00-05:00,TNDM,positive
1243233.0,Tandem Diabetes Care Reports Commencement Of Full Manufacturing Operations At New San Diego Facility,2018-01-03 09:03:00-05:00,TNDM,positive
1243234.0,Tandem Diabetes Care Reports Issuance Of Patent Related To Automated Insulin Delivery Technology,2017-12-14 09:00:00-05:00,TNDM,positive
1243235.0,"Tandem Diabetes Care Reports CFO John Cajigas To Retire; Senior VP Of Finance, Leigh Vosseller, Promoted To CFO",2017-12-07 16:50:00-05:00,TNDM,positive
1243236.0,"Piper Jaffray Healthcare Conference Concludes Today, Presenters Include: Kadmon, Ignyta, Eagle Pharmaceuticals, Tandem Diabetes Care, DexCom, and Alnylam Pharmaceuticals",2017-11-29 09:30:00-05:00,TNDM,positive
1243237.0,"Bank of America Maintains Underperform on Tandem Diabetes Care, Lowers Price Target to $2.00",2017-11-20 09:43:00-05:00,TNDM,positive
1243238.0,"Stifel 2017 Healthcare Conference Begins Today, Presenters Include: Seres Therapeutics, Verastem, TherapeuticsMD, Aerie Pharmaceuticals, Mednax, Celgene, TransEnterix, Exelixis, Tandem Diabetes Care and Masimo",2017-11-14 09:36:00-05:00,TNDM,positive
1243239.0,Tandem Diabetes Care Receives New European Patent Related To Its T-FLEX Insulin Delivery System,2017-11-08 13:54:00-05:00,TNDM,positive
1243240.0,13G Filing Shows Intracoastal Capital Reporting 4.1% Stake In Tandem Diabetes Care,2017-10-26 17:26:00-04:00,TNDM,positive
1243241.0,"Tandem Diabetes Care Sees FY17 Adj. Sales $95M-$100M, GAAP Sales $100M-$105M vs $101.96M Est.",2017-10-26 16:31:00-04:00,TNDM,positive
1243242.0,"Tandem Diabetes Care Reports Q3 EPS $(3.09) vs $(3.74) Est., Sales $27.003M vs $25.91M Est.",2017-10-26 16:30:00-04:00,TNDM,positive
1243243.0,"UPDATE: Tandem Diabetes Says Cash, Cash Equivalents, Short-Term Investments As Of Sept. 30, 2017 ~$22.5M",2017-10-13 06:13:00-04:00,TNDM,neutral
1243244.0,"Tandem Diabetes Care 8-K Shows Prelim. Q3 Results: Shipped Aggregate Of 3,868 Pumps, Sees Sales ~$26.5M-$27.5M vs $26.1M Est.",2017-10-13 06:12:00-04:00,TNDM,positive
1243245.0,"Tandem Diabetes Care Reports Proposed Offering Of Common Stock, Series A, B Warrants",2017-10-12 16:01:00-04:00,TNDM,positive
1243246.0,Tandem Diabetes Board Authorized To Effect 1-for-8 Reverse Stock Split,2017-10-09 09:02:00-04:00,TNDM,neutral
1243247.0,Tandem Diabetes Reports 1/3 Of t:slim X2 Pump Users Already Updated Their Pumps Via Personal Computer To Add New Dexcom G5 CGM Integration,2017-09-28 08:34:00-04:00,TNDM,neutral
1243248.0,Tandem Diabetes Care Reports FDA Approval And Launch Of t:slim X2 Insulin Pump With Dexcom G6 Mobile CGM Integration,2017-08-28 08:31:00-04:00,TNDM,positive
1243249.0,Tandem Diabetes Reports Issuance Of Patent Related To Remote Bolus Feature For Medical Infusion Pumps,2017-08-24 16:11:00-04:00,TNDM,neutral
1243250.0,"Wedbush PacGrow Healthcare Conference Begins Today, Presenters Include: Omeros, Bovie Medical, Bluebird Bio, Juno Therapeutics, DexCom, Tandem Diabetes, and Insulet",2017-08-15 08:40:00-04:00,TNDM,neutral
1243251.0,Tandem Diabetes Reports Commencement Of Enrollment In Pivotal Trial For First Touchscreen Insulin Pump In PLGS,2017-08-15 08:38:00-04:00,TNDM,neutral
1243252.0,"Tandem Diabetes Care Reports Issuance of Patent No. 9,715,327 Related to Important Safety Features for Portable Infusion Pumps that Utilize Touchscreen Control",2017-08-08 08:31:00-04:00,TNDM,positive
1243253.0,Tandem Diabetes Care Sees FY17 Sales $100-107M vs $102.91M Est.,2017-07-27 17:16:00-04:00,TNDM,positive
1243254.0,"Tandem Diabetes Care Reports Q2 EPS $(0.44) vs $(0.48) Est., Sales $21.33M vs $21.74M Est.",2017-07-27 17:15:00-04:00,TNDM,positive
1243255.0,Tandem Diabetes Reaffirms FY17 Outlook: Adj. Sales $100M-$107M vs $102.6M Est.,2017-04-27 17:00:00-04:00,TNDM,neutral
1243256.0,"Tandem Diabetes Reports Q1 EPS $(0.75) vs $(0.64) Est., Sales $18.977M vs $15.72M Est.",2017-04-27 16:59:00-04:00,TNDM,neutral
1243257.0,Tandem Diabetes Care Prices 18M Share Offering At $1.25/Share,2017-03-23 08:31:00-04:00,TNDM,positive
1243258.0,Tandem Diabetes 18M Offering at $1.25/Share,2017-03-23 06:36:00-04:00,TNDM,neutral
1243259.0,Tandem Diabetes Offering 18M Shares for ~$20.7M,2017-03-23 06:36:00-04:00,TNDM,positive
1243260.0,Tandem Diabetes Announces Registration For Follow-on Public Offering Of $50M In Common Stock,2017-03-08 16:33:00-05:00,TNDM,neutral
1243261.0,"Tandem Diabetes Reports Q4 Sales $24.8M vs $22.8M Est., EPS $(0.48) vs $(0.40) in Same Qtr. Last Year",2017-03-08 16:12:00-05:00,TNDM,neutral
1243262.0,Tandem Diabetes Reports Launch of First-Ever Remote Software Update for Insulin Pump Using Personal Computer,2017-03-02 08:36:00-05:00,TNDM,neutral
1243263.0,"PiperJaffray Downgrades Tandem Diabetes Care, Inc. - Common Stock to Neutral",2016-11-03 06:39:00-04:00,TNDM,positive
1243264.0,"Earlier Feltl & Co. Downgraded Tandem Diabetes Care, Inc. - Common Stock to Buy",2016-11-02 11:33:00-04:00,TNDM,positive
1243265.0,"Baird Downgrades Tandem Diabetes Care, Inc. - Common Stock to Neutral",2016-11-02 07:54:00-04:00,TNDM,positive
1243266.0,"Stifel Nicolaus Downgrades Tandem Diabetes Care, Inc. - Common Stock to Hold",2016-11-02 06:01:00-04:00,TNDM,positive
1243267.0,"B. Riley Initiates Coverage on Tandem Diabetes Care at Buy, Announces $10.00 PT",2016-09-27 04:01:00-04:00,TNDM,positive
1243268.0,Bank of America Downgrades Tandem Diabetes Care to Underperform,2016-03-24 07:26:00-04:00,TNDM,positive
1243269.0,"Baird Initiates Coverage on Tandem Diabetes Care at Outperform, Announces $15.00 PT",2015-07-08 07:13:00-04:00,TNDM,positive
1243270.0,Tandem Diabetes Care Prices 5.25M Share Offering @$11.50/Share,2015-02-27 04:42:00-05:00,TNDM,positive
1243271.0,"Cowen & Company Initiates Coverage on Tandem Diabetes Care at Outperform, Announces $16.00 PT",2014-12-08 06:24:00-05:00,TNDM,positive
1243272.0,William Blair Initiates Coverage on Tandem Diabetes Care at Outperform,2014-07-15 18:06:00-04:00,TNDM,positive
1243273.0,"Deutsche Bank Upgrades Tandem Diabetes Care to Buy, Lowers PT to $25.00",2014-05-14 06:54:00-04:00,TNDM,positive
1243274.0,Tandem Diabetes Care Reports Q4 EPS of $(2.14) vs $(1.14) Est,2014-03-06 16:16:00-05:00,TNDM,positive
1243275.0,Tandem Diabetes Care Expands Voluntary Recall for Select Lots of Insulin Cartridges Used with t:slim Insulin Pump ,2014-01-20 17:53:00-05:00,TNDM,positive
1243276.0,"Stifel Nicolaus Initiates Coverage on Tandem Diabetes Care at Buy, Announces $30.00 PT",2013-12-09 08:52:00-05:00,TNDM,positive
1243277.0,"Piper Jaffray Initiates Coverage on Tandem Diabetes Care at Overweight, Announces $27.00 PT",2013-12-09 08:52:00-05:00,TNDM,positive
1243278.0,"Bank of America Initiates Coverage on Tandem Diabetes Care at Neutral, Announces $27.00 PO",2013-12-09 06:29:00-05:00,TNDM,negative
1243279.0,"Deutsche Bank Initiates Coverage on Tandem Diabetes Care at Hold, Announces $26.00 PT",2013-12-09 06:24:00-05:00,TNDM,positive
1243280.0,IPO for Tandem Diabetes Care Opens at $19.50 After Pricing at $15,2013-11-14 10:37:00-05:00,TNDM,positive
1243282.0,Morgan Stanley Maintains Equal-Weight Rating on Neutral Tandem  ,2011-11-17 07:53:00-05:00,TNDM,neutral
1243283.0,Notable Call Options Activity in Neutral Tandem,2011-11-14 14:56:00-05:00,TNDM,neutral
1243284.0,Notable Call Options Activity in Neutral Tandem,2011-11-14 14:54:00-05:00,TNDM,neutral
1243285.0,Oppenheimer Maintains Perform Rating on Neutral Tandem ,2011-11-09 09:27:00-05:00,TNDM,neutral
1243286.0,Neutral Tandem Reports Q3 EPS $0.18 vs $0.24 Est; Revenues $67.30M vs $66.56M Est	 		,2011-11-08 08:06:00-05:00,TNDM,neutral
1243287.0,Disclosure Insight Maintains Medium Risk Rating on Neutral Tandem ,2011-11-01 07:04:00-04:00,TNDM,negative
1243288.0,Wedbush Neutral On Neutral Tandem ,2011-08-09 15:35:00-04:00,TNDM,neutral
1243289.0,mNeutral Tandem Reports Q2 EPS $0.20 vs $0.24 Est; Revenues $65.1 vs $66.72M Est			,2011-08-09 07:15:00-04:00,TNDM,neutral
1243290.0,"Morgan Stanley Voices Concerns about Natural Tandem's Voice Products, EtherCloud",2011-06-22 08:05:00-04:00,TNDM,positive
1243291.0,UPDATE: Wedbush Color on Neutral Tandem PT Increase,2011-06-15 08:14:00-04:00,TNDM,positive
1243292.0,Wedbush Raises PT On Neutral Tandem To $17,2011-06-15 06:19:00-04:00,TNDM,neutral
1243293.0,Neutral Tandem Falling over 4% After Tendered Shares,2011-06-14 10:46:00-04:00,TNDM,positive
1243294.0,"Neutral Tandem Announces Preliminary Results of ""Modified Dutch Auction"" Tender Offer, Reported Earlier",2011-06-14 10:44:00-04:00,TNDM,neutral
1243295.0,Neutral Tandem Announces Commencement of Tender Offer to Purchase up to $50 Million of Common Stock ,2011-05-12 08:05:00-04:00,TNDM,neutral
1243296.0,Oppenheimer Reports on Neutral Tandem (TNDM),2011-05-11 07:11:00-04:00,TNDM,neutral
1243297.0,"Calls Purchased on Neutral Tandem, Inc. (TNDM)",2011-04-19 12:33:00-04:00,TNDM,neutral
1243298.0,Calls Purchased on Neutral Tandem (TNDM),2011-03-25 13:54:00-04:00,TNDM,neutral
1243299.0,Morgan Stanley Reports Neutral Tandem's Strong Return Of Capital Profile Still Subject To Significant Pricing Drag,2011-03-16 07:08:00-04:00,TNDM,positive
1243300.0,"Earnings Scheduled For March 14 (JST, DOLE, MEMS, AIS, ZAGG, CPE, TNDM, GPOR, CHDN, OPTT, ULTR, IRET, GVP, PRST)",2011-03-14 03:36:00-04:00,TNDM,neutral
1243301.0,"Stocks To Watch For March 14 (DOLE, TNDM, ZAGG, CHDN, GPOR)",2011-03-14 03:28:00-04:00,TNDM,neutral
1243302.0,Neutral Tandem CEO Takes Voluntary Retirement,2011-02-23 08:08:00-05:00,TNDM,neutral
1243303.0,Calls Purchased on Neutral Tandem (TNDM),2011-02-10 11:41:00-05:00,TNDM,neutral
1243304.0,"Top 4 Stocks In The Wireless Communications Industry With The Highest Profit Margin (IDCC, CHL, TNDM, PTNR)",2010-11-10 04:37:00-05:00,TNDM,positive
1243305.0,Neutral Tandem Up 6.3% On Earnings Beat (TNDM),2010-11-09 14:47:00-05:00,TNDM,neutral
1243306.0,Neutral Tandem Beats Estimates (TNDM),2010-11-09 08:36:00-05:00,TNDM,neutral
1243307.0,Neutral Tandem Completes $99.8M Acquisition of Tinet SpA  ,2010-10-01 11:04:00-04:00,TNDM,neutral
1243308.0,"Benzinga's Top Pre-Market NASDAQ Losers (CLDX, MITL, TNDM, ZIXI)",2010-09-07 09:10:00-04:00,TNDM,negative
1243309.0,It Could be Worse - You Got Vistaprinted! (VPRT),2010-07-29 14:42:00-04:00,TNDM,negative
1243310.0,"Benzinga’s Top Downgrades (BWY , TNDM, CALM, GNVC, MPG)",2010-03-30 10:45:00-04:00,TNDM,positive
1243311.0,TNDM Downgraded On Patent Uncertainty,2010-03-30 09:13:00-04:00,TNDM,negative
1243312.0,"Benzinga’s Top Pre-Market Losers (TNDM, GNVC, HPJ, MYGN)",2010-03-30 08:19:00-04:00,TNDM,negative
1243313.0,Investment Analysis: Neutral Tandem (TNDM) – A Stunningly Cheap Telecom Stock,2010-03-29 14:26:00-04:00,TNDM,neutral
1243314.0,Neutral Tandem (TNDM) Announces Repurchase Program With 4Q Results ,2010-02-16 14:12:00-05:00,TNDM,negative
1243315.0,"Benzinga’s Top Pre- Market Gainers (ACAS, GRMN, TNDM, ARNA)",2009-11-04 09:03:00-05:00,TNDM,positive
1243316.0,"WallStSense.com Fundamental & Technical Coverage of PCLN, STEC, VITA, YRCW, ACAS and TNDM",2009-08-14 06:46:00-04:00,TNDM,neutral
